The mechanisms by which enteropathogenic E. coli (EPEC) cause diarrhea are not fully defined despite years of investigation. Tight junctions (TJs) regulate water and ion movement in the intestine and protect the sterile compartments beneath the single layer of epithelial cells from luminal contents. EPEC alter dramatically TJ structure and function by injecting effector molecules into intestinal epithelial cells via a type III secreton system (T3SS). The long-term goal of this proposal is to gain a better understanding of how multiple EPEC effectors coordinate to disrupt TJs. The independent and coordinated activities of four T3SS effector proteins (EspF, Map, EspG, NleA) will be studied. TJs remodel constantly to maintain homeostasis and undergo restoration. Preliminary data support that EPEC effectors interfere with homeostatic and restorative processes including cell polarity, TJ protein recycling,and trafficking of newly synthesized proteins. The objective, in pursuit of this goal, is to definehow specific EPEC effectors cooperate to alter host cell processes that stabilize intact TJs and block those that restore disrupted TJs. The central hypothesis is that EPEC perturbation of TJs is a 2-hit process involving dismantling of intact TJ by EspF and Map, and hindrance of TJ restoration by EspG and NleA by interfering with TJ protein recycling and the transport of newly synthesized TJ proteins. In vitro and in vivo models will be used to study infection with wildtype EPEC as well as key mutant strains. State-of- the-art microscopic techniques will be coupled with molecular, cellular, microbiological, protein biochemistry, and physiological approaches to achieve the stated goals. Definition of the events by which bacterial pathogens perturb TJs and of the processes involved in TJ maintenance and restoration will guide the development of strategies aimed at preserving and restoring these important structures under adverse circumstances. The central hypothesis will be tested by addressing the following Specific Aims: 1. Define the mechanisms underlying disruption of intact TJs by EPEC and investigate the cooperative relationship between specific effectors.
Aim 1 will define how EspF and Map coordinate to impact cell polarity and TJs in order to identify a single clear target for novel therapeutic interventions. 2. Determine the effect of EPEC on TJ restoration and identify the effectors and mechanisms responsible.
Aim 2 will address the effect of EspG-induced microtubule disruption on TJ protein recycling and restoration as well as inhibition of ER-Golgi trafficking by NleA on restoration of TJs dismantled by other effectors, such as EspF and Map. 3. Resolve the mechanisms of TJ disruption by EPEC in an in vivo model.
Aim 3 will validate the findings of Aims 1 and 2 in an in vivo model using state-of-the-art techniques. The completion of these studies will lead not only to a better understanding of EPEC pathogenesis but also to the identification of preventative and therapeutic approaches for preserving TJs.

Public Health Relevance

This work is relevant to public health because enteropathogenic E. coli (EPEC) is a cause of severe diarrheal disease and also serves as a model pathogen for enterohemorrhagic E. coli (EHEC), the cause of several recent food-borne outbreaks in the United States. EPEC causes diarrhea in part by destroying tight junctions (TJs), the structures that prevent the passage of noxious intestinal contents between the cells that line the intestine. Understanding how EPEC proteins disrupt the structure and function of TJs and maintain that disruption will allow for the development of new strategies for preserving and restoring these important structures.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
High Priority, Short Term Project Award (R56)
Project #
2R56DK050694-15A1
Application #
8449899
Study Section
Gastrointestinal Mucosal Pathobiology Study Section (GMPB)
Program Officer
Grey, Michael J
Project Start
1997-06-01
Project End
2013-03-05
Budget Start
2012-05-01
Budget End
2013-03-05
Support Year
15
Fiscal Year
2012
Total Cost
$181,409
Indirect Cost
$65,862
Name
University of Illinois at Chicago
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
098987217
City
Chicago
State
IL
Country
United States
Zip Code
60612
Kralicek, Sarah E; Nguyen, Mai; Rhee, Ki-Jong et al. (2018) EPEC NleH1 is significantly more effective in reversing colitis and reducing mortality than NleH2 via differential effects on host signaling pathways. Lab Invest 98:477-488
Nguyen, Mai; Rizvi, Jason; Hecht, Gail (2015) Expression of enteropathogenic Escherichia coli map is significantly different than that of other type III secreted effectors in vivo. Infect Immun 83:130-7
Battle, Scott E; Brady, Michael J; Vanaja, Sivapriya Kailasan et al. (2014) Actin pedestal formation by enterohemorrhagic Escherichia coli enhances bacterial host cell attachment and concomitant type III translocation. Infect Immun 82:3713-22
Glotfelty, Lila G; Zahs, Anita; Hodges, Kimberley et al. (2014) Enteropathogenic E. coli effectors EspG1/G2 disrupt microtubules, contribute to tight junction perturbation and inhibit restoration. Cell Microbiol 16:1767-83
Glotfelty, Lila G; Zahs, Anita; Iancu, Catalin et al. (2014) Microtubules are required for efficient epithelial tight junction homeostasis and restoration. Am J Physiol Cell Physiol 307:C245-54
Hodges, Kim; Hecht, Gail (2013) Bacterial infections of the small intestine. Curr Opin Gastroenterol 29:159-63
Glotfelty, Lila G; Hecht, Gail A (2012) Enteropathogenic E. coli effectors EspG1/G2 disrupt tight junctions: new roles and mechanisms. Ann N Y Acad Sci 1258:149-58
Annaba, Fadi; Sarwar, Zaheer; Gill, Ravinder K et al. (2012) Enteropathogenic Escherichia coli inhibits ileal sodium-dependent bile acid transporter ASBT. Am J Physiol Gastrointest Liver Physiol 302:G1216-22
Vingadassalom, Didier; Campellone, Kenneth G; Brady, Michael J et al. (2010) Enterohemorrhagic E. coli requires N-WASP for efficient type III translocation but not for EspFU-mediated actin pedestal formation. PLoS Pathog 6:e1001056
Thanabalasuriar, Ajitha; Koutsouris, Athanasia; Weflen, Andrew et al. (2010) The bacterial virulence factor NleA is required for the disruption of intestinal tight junctions by enteropathogenic Escherichia coli. Cell Microbiol 12:31-41

Showing the most recent 10 out of 13 publications